Preparation, characterization and antitumor activity evaluation of apigenin nanoparticles by the liquid antisolvent precipitation technique

References

• Al Shaal L, Müller RH, Shegokar R. (2010). SmartCrystal combination technology: scale up from lab to pilot scale and long term stability. Pharmazie 65:877–84.
   PubMed Web of Science ®Google Scholar
• Al Shaal L, Shegokar R, Müller RH. (2011). Production and characterization of antioxidant apigenin nanocrystals as a novel UV skin protective formulation. Int J Pharm 420:133–40.
   PubMed Web of Science ®Google Scholar
• Balasubramanian S, Eckert R. (2007). Keratinocyte proliferation, differentiation, and apoptosis-differential mechanisms of regulation by curcumin, EGCG and apigenin. Toxicol Appl Pharmacol 224:214–9.
   PubMed Web of Science ®Google Scholar
• Banerjee K, Banerjee S, Das S, Mandal M. (2015). Probing the potential of apigenin liposomes in enhancing bacterial membrane perturbation and integrity loss. J Colloid Interface Sci 453:48–59.
   PubMed Web of Science ®Google Scholar
• Banerjee K, Banerjee S, Mandal M. (2017). Enhanced chemotherapeutic efficacy of apigenin liposomes in colorectal cancer based on flavone-membrane interactions. J Colloid Interface Sci 491:98–110.
   PubMed Web of Science ®Google Scholar
• Ding S, Zhang Z, Song J, Cheng X, Jiang J, Jia X. (2014). Enhanced bioavailability of apigenin via preparation of a carbon nanopowder solid dispersion. International Journal of Nanomedicine 9:2327–33.
   PubMed Web of Science ®Google Scholar
• Dong Y, Ng WK, Hu J, et al. (2010). A continuous and highly effective static mixing process for antisolvent precipitation of nanoparticles of poorly water-soluble drugs. Int J Pharmaceut 386:256–61.
   PubMed Web of Science ®Google Scholar
• Jin X, Yang Q, Zhang Y. (2017). Synergistic apoptotic effects of apigenin TPGS liposomes and tyroservatide: implications for effective treatment of lung cancer. Ijn 12:5109–18.
   Web of Science ®Google Scholar
• Kesisoglou F, Panmai S, Wu Y. (2007). Nanosizing: oral formulation development and biopharmaceutical evaluation. Adv Drug Deliv Rev 59:631.
   PubMed Web of Science ®Google Scholar
• Kim BK, Cho AR, Park DJ. (2016). Enhancing oral bioavailability using preparations of apigenin-loaded W/O/W emulsions: in vitro and in vivo evaluations. Food Chem 206:85–91.
   PubMed Web of Science ®Google Scholar
• Kim S, Ng WK, Dong Y, et al. (2012). Preparation and physicochemical characterization of trans-resveratrol nanoparticles by temperature-controlled antisolvent precipitation. J Food Eng 108:37–42.
   Web of Science ®Google Scholar
• Li G, Chi CW, Shao XF, Fang CH. (2017). Application of molecular imaging technology in evaluating the inhibiting effect of apigenin in vivo on subcutaneous hepatocellular carcinoma. Biochem Biophys Res Commun 487:122–7.
   PubMed Web of Science ®Google Scholar
• Li J. (2014). Study and Characterization of the Antioxidant Activity of the Inclusion Complex of Apigenin with beta-Cyclodextrin and HP-beta-Cyclodextrin in solution. J Invest Biochem 3:107.
   Google Scholar
• Merisko-Liversidge E, Liversidge GG, Cooper ER. (2003). Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur J Pharm Sci 18:113–20.
   PubMed Web of Science ®Google Scholar
• Qian S, Fan W, Qian P, et al. (2015). Apigenin restricts FMDV infection and inhibits viral IRES driven translational activity. Viruses 7:1613–26.
   PubMed Web of Science ®Google Scholar
• Shen LN, Zhang YT, Wang Q, et al. (2014). Enhanced in vitro and in vivo skin deposition of apigenin delivered using ethosomes. Int J Pharm 460:280–8.
   PubMed Web of Science ®Google Scholar
• Singh B, Sahu AK, Prasad RK, Gautam SS. (2014). Preparation and characterization of Cilnidipine nanoparticles for oral antihypertensive drug using anti-solvent precipitation method. Eur J Pharm Sci 53:109–17.
   PubMed Web of Science ®Google Scholar
• Telange DR, Patil AT, Pethe AM, Fegade H, Anand S, Dave VS. (2016). Formulation and characterization of an apigenin-phospholipid phytosome (APLC) for improved solubility, in vivo bioavailability, and antioxidant potential. Eur J Pharm Sci 108:36–49.
   PubMed Web of Science ®Google Scholar
• Viçosa A, Letourneau JJ, Espitalier F, Ré MI. (2012). An innovative antisolvent precipitation process as a promising technique to prepare ultrafine rifampicin particles. J Crystal Growth 342:80–7.
   Web of Science ®Google Scholar
• Yadav D, Kumar N. (2014). Nanonization of curcumin by antisolvent precipitation: Process development, characterization, freeze drying and stability performance. Int J Pharm 477:564–77.
   PubMed Web of Science ®Google Scholar
• Zhai Y, Guo S, Liu C, et al. (2013). Preparation and in vitro evaluation of apigenin-loaded polymeric micelles. Colloids Surf A 429:24–30.
   Web of Science ®Google Scholar
• Zhang HX, Wang JX, Zhang ZB, et al. (2009). Micronization of atorvastatin calcium by antisolvent precipitation process. Int J Pharm 374:106.
   PubMed Web of Science ®Google Scholar
• Zhang J, Huang Y, Liu D, et al. (2013). Preparation of apigenin nanocrystals using supercritical antisolvent process for dissolution and bioavailability enhancement. Eur J Pharm Sci 48:740–7.
   PubMed Web of Science ®Google Scholar
• Zhang J, Liu D, Huang Y, et al. (2012). Biopharmaceutics classification and intestinal absorption study of apigenin. Int J Pharm 436:311–7.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Cui C, Wei F, Lv H. (2017). Improved solubility and oral bioavailability of apigeninvia soluplus®/pluronic F127binary mixed micelles system. Drug Develop Ind Pharm 43:1.
   PubMed Web of Science ®Google Scholar
• Zhao X, Song K, Wang S, et al. (2013). Micronization of the pharmaceutically active agent genipin by an antisolvent precipitation process. Chem Eng Technol 36:33–42.
   Web of Science ®Google Scholar
• Zhao X, Wang Z, Li X. (2016). Preparation, in-vitro release and antioxidant potential of formulation of apigenin with hydroxypropyl-β-cyclodextrin modified microemulsion. J Incl Phenom Macrocycl Chem 86:93–102.
   Web of Science ®Google Scholar
• Zhe W, Chen JF, Le Y, Shen ZG, Yun J. (2007). Preparation of ultrafine beclomethasone dipropionate drug powder by antisolvent precipitation. Ind Eng Chem Res 46:4839–45.
   Web of Science ®Google Scholar
• Zu Y, Sun W, Zhao X, et al. (2013). Preparation and characterization of amorphous amphotericin B nanoparticles for oral administration through liquid antisolvent precipitation. Eur J Pharm Sci 53:109–17.
   PubMed Web of Science ®Google Scholar
• Zu Y, Wu W, Zhao X, Li Y, Wang W, Zhong C, Zhang Y. (2014). Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique. Int J Pharmaceut 471:366.
   PubMed Web of Science ®Google Scholar